Barely Significant
← all excerpts

Pathomic immune biomarkers define recurrence risk in early-stage melanoma.

Oncologist · 2025 · PMC12573246 · PMID 41052286

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantP = .001actually significant
When DMFS was analyzed in the stage IIB-IIIA cohort specifically, results were highly significant for all three individual biomarkers as shown in Figure S5 ( P = .001, P = .017, and P = .001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.